Walvax Biotechnology Co., Ltd. (SHE:300142)
12.79
-0.06 (-0.47%)
Apr 29, 2026, 10:25 AM CST
26.13% (1Y)
| Market Cap | 20.55B |
| Revenue (ttm) | 2.40B |
| Net Income (ttm) | 285.77M |
| Shares Out | 1.60B |
| EPS (ttm) | 0.18 |
| PE Ratio | 72.42 |
| Forward PE | 70.41 |
| Dividend | 0.16 (1.21%) |
| Ex-Dividend Date | Jan 9, 2026 |
| Volume | 43,594,119 |
| Average Volume | 45,290,877 |
| Open | 11.90 |
| Previous Close | 12.85 |
| Day's Range | 11.90 - 12.98 |
| 52-Week Range | 9.85 - 14.65 |
| Beta | 0.47 |
| RSI | 58.01 |
| Earnings Date | Apr 28, 2026 |